W. L. Gore & Associates
Gore Provides Update on Patent Foramen Ovale PFO Stroke Study
Published in Medical Letter on the CDC and FDA, July 25th, 2010
W. L. Gore & Associates (Gore) today provided an update on the Gore REDUCE Clinical Study*, a prospective, randomized, multi-center, multi-national trial designed to demonstrate safety and effectiveness of the GORE HELEX Septal Occluder for Patent Foramen Ovale (PFO) closure in patients with history of cryptogenic stroke or imaging-confirmed Transient Ischemic Attack (TIA). The unique study, which includes up to fifty investigational sites in the U.S., Denmark, Finland, Norway and Sweden, is on track to meet its estimated completion in 2015.
"In light of the recent press release regarding the preliminary results of CLOSURE I, we felt it important to re-emphasize our...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
More Articles from Medical Letter on the CDC and FDA
- U.S. Food and Drug Administration
"Potent" Marijuana Now Available in E-Cigarettes // Devices Used On Planes and Elsewhere Give "Vapor Rush" - U.S. Food and Drug Administration
BioPharma and Life-Sciences Firms Face 'A Difficult Time,' Attorneys Say - U.S. Food and Drug Administration
NBC's TODAY Show Utilizes EMSL Analytical's Food Testing Laboratory - Biochemistry
Researchers from Center for Food Safety and Applied Nutrition report on findings in biochemistry - Health and Medicine
Study data from Johns Hopkins University provide new insights into health and medicine - Biological Products
Data on biological products detailed by researchers at University of Ottawa - More from this issue of Medical Letter on the CDC and FDA
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
